2020

NAL ON10th Annual Conference of Indian Society for Study of Lung Cancer

th th 26 - 27 September 2020 rd th3 & 4 October 2020

STREAMING LIVE ON

A VIRTUAL PLATFORM

Organising Committee

Patron: Dr Harit Chaturvedi

Organising Chairperson: Dr Meenu Walia

Organising Co-Chairperson: Dr Gopal Sharma

Scientific Chairperson: Dr Nitesh Rohatgi

Organising Secretary: Dr Shubham Garg

Surgical, Program Lead: Dr Shubham Jain

Medical, Program Lead: Dr Sajjan Rajpurohit

Radiation, Program Lead: Dr Charu Garg

Pulmonology, Core Committee:

Dr Ajay Lall

Dr Praveen Pandey

Dr Vivek Nangia

Dr Sharad Joshi

Organising Committee

Dr Ashish Jain Dr Waseem Abbas Dr Rashi Aggarwal

Dr Prekshi Chaudhary Dr Archit Pandit Dr Nevin Kishore

Dr Puneet Gupta Dr Nitin Rathi Dr I M Chugh

ISSLC Ofce BearersPatron: Dr D Behera

Vice Presidents: Dr P R Mohapatra, Dr Ravi Arjunan

Secretary: Dr Navneet Singh

Joint Secretary: Dr K T Prasad

Treasurer: Dr Ashutosh N Aggarwal

Executive Members:

Dr Rakesh Kapoor

Dr Surender Kashyap

Dr Madhabananda Kar

Dr Anant Mohan

Dr C S Pramesh

Dr C Sairam

Dr J K Singh (co-opted)

Dr Surya Kant (co-opted)

HALL A

Time Topic Speaker/Panelist Moderator/Chairperson

0400 - 0430 PMCase based discussion on

incidental solitary nodule

Panelists –

Dr Ashu Bhalla, Delhi

Dr Aditi Dewan, Delhi

Dr Prriya Eshpuniyani, Mumbai

Dr Bharat Dua, Delhi

Dr P Mohapatra, Bhubaneswar

Moderator-

Dr Shubham Jain, Delhi

0430 - 0445 PMPathological Spectrum of

preinvasive lesions on screening Dr Sunil Pasricha, Delhi

Dr Urmi Mukherjee, Delhi

Dr Arvind Chaturvedi, Delhi

0445 - 0500 PMUnderstanding LDCT -

LUNGRADSDr Amit Janu, Mumbai

0500 - 0530 PM

Keynote - Understanding

Disease Burden in India & Role

of Screening

Keynote Speaker

Dr D Behera, Chandigarh Expert Comments:

Dr C S Pramesh, Mumbai

Dr G K Rath, Delhi

0530 - 0600 PMKeynote - Importance of

Mediastinal Staging

Keynote Speaker

Dr Ramon Rami Porta, Spain

Dr Marcin Zielinski, Poland

0600 - 0615 PMFeasibility of Lung Cancer

Screening in IndiaDr Devayani Niyogi, Mumbai

Dr Anant Mohan, Delhi

Dr Naseer Yusuf, Kochi

Dr Amit Dutt, Mumbai0615 - 0640 PM

Debate – Mediastinoscopy is

redundant for mediastinal

staging for Lung Cancer

For the motion - Dr Prashant

Nemichand Chhajed, Mumbai

Against the motion -

Dr George K, Mumbai

0640 - 0700 PMNon Radiological Options for

Lung Cancer ScreeningDr Vineet Datta, Nashik

0700 - 0800 PM Inauguration

2020

NAL ONScientic Program

thSaturday, 26 September 2020

HALL B

Time Topic Speaker/Panelist Moderator/Chairperson

0400 - 0430 PM Case based discussion on incidental solitary nodule in Hall A

0430 - 0445 PMPractical Aspects of TNM

Staging (8th)Dr Vikas Talreja, Delhi

Dr S V S Deo, Delhi

Dr J K Singh, Patna

Dr Syamal Sarkar, Ranchi0445 - 0500 PMTowards 9th Edition of

TNMDr Navneet Singh, Chandigarh

0500 - 0530 PM Keynote - Understanding Disease Burden in India & Role of Screening in Hall A

0530 - 0600 PM Keynote - Importance of Mediastinal Staging in Hall A

0600 - 0615 PM

How Tuberculosis

masquerades as Lung

Cancer and delays

diagnosis

Dr T Balamugesh, Vellore

Dr Sudhir Chaudhary,

Kanpur

Dr Ajay Lall, Delhi

Dr G C Khilnani, Delhi0615 - 0640 PM

All that glitters is not

cancer. In Conversation -

DOCTORS with Halo

Moderator -

Dr Jaspriya Bal, Delhi

Panelists -

Dr Nilendu Purandare, Mumbai

Dr Suryakant, Lucknow

Dr Kinjal Jani, Ahmedabad

Dr Harshvardhan Puri, Delhi

0640 - 0700 PMUnderstanding Survival

Statistics for Lung CancerDr Purvish Parikh, Mumbai

0700 - 0800 PM Inauguration in Hall A

2020

NAL ONScientic Program

thSaturday, 26 September 2020

HALL A

Time Topic Speaker/Panelist Moderator/Chairperson

0400 - 0430 PMCase based discussion on

operable early lung cancer

Panelists -

Dr J C Suri, Delhi

Dr J Mathangi, Bangalore

Dr S K Jain, Delhi

Dr Jyoti Wadhwa, Delhi

Moderator -

Dr Shubham Garg, Delhi

0430 - 0445 PMIdeal sequence of workup with

ERAS Dr Sandeep Tandon, Mumbai Dr Praveen Pandey, Delhi

Dr Mrinal Sircar, Delhi

Dr Madhabanda Kar,

Bhubaneshwar0445 - 0500 PM Decoding PFTs for Oncologist Dr Ali Zamir Khan, UK

0500 - 0530 PM

Keynote – Can we further reduce

the invasiveness of Minimal

Access Surgery for Lung Cancer

Keynote Speaker -

Dr Diego Gonzalez Rivas, Spain

Expert Comments

Dr Arvind Kumar, Delhi

Dr Rajesh Mistry, Mumbai

0530 - 0600 PMKeynote – Knife vs

Xknife – SBRT

International Speaker

Dr John Conibear, UK

Expert Comments

Dr J P Aggarwal, Mumbai

Dr S Hukku, Delhi

0600 - 0620 PMPathological Dissection of Lung

SpecimenDr Rajiv Kumar, Mumbai

Expert Comments –

Dr Amanjit Bal, Chandigarh

Dr Anuj Khurana, Delhi

0620 - 0635 PMAir Leak Following Lung Cancer

SurgeryDr Ravindra Dewan, Delhi

Dr L M Darlong, Delhi

Dr Anil Kapoor, Merrut

Dr Arvind Krishnamurthi,

Chennai

0635 - 0650 PMWhen Can you offer surgery for

Small Cell Lung Cancer

Dr Prashant Pneumadu,

Puducherry

0650 - 0705 PMSurgery in metastatic lung cancer –

few but certainly benefial indications

and how to choose the right patient

Dr Sabita Jiwnani, Mumbai

0705 - 0720 PMSRS in brain mets – numbers and

time – whats the limit !Dr Kundan Chaufal, Delhi

Dr Jyotika Jain, Delhi

Dr Manoj Tayal, Delhi0715 - 0730 PM

WBRT with hippocampal sparing

– when NOT Dr Sayan Paul, Hyderabad

0730 - 0800 PMAam aadmi with lung cancer –

Find me a cost effective solutionDr Kumar Prabash, Mumbai

Dr Vinod Raina, Gurugram

Dr Rakesh Chopra,

Gurugram

2020

NAL ONScientic Program

thSunday, 27 September 2020

HALL B

Time Topic Speaker/Panelist Moderator/Chairperson

0400 - 0430 PM Case based discussion on operable early lung cancer in Hall A

0430 - 0445 PM

Looking Back to Find a Way

Forward – Why Surgery for Lung

Cancer lags behind in India

Dr R K Deshpande, Mumbai

Dr Bhabatosh Biswas,

Kolkata

Dr S Bal, Delhi

Dr Rakesh Kapoor,

Chandigarh0445 - 0500 PM

Made for Each Other – What a

surgeon should ask a radiation

oncologist and vice versa when

planning multimodality treatment

for lung cancer

Dr Durgatosh Pandey, Varanasi

Dr Rambha Pandey, Delhi

0500 - 0530 PMKeynote – Can we further reduce the

invasiveness of Minimal Access Surgery for Lung Cancer in Hall A

0530 - 0600 PM Keynote – Knife vs XKnife – SBRT in Hall A

0600 - 0620 PMPoint of view – Central Tumors –

SBRT or Sleeve Resections

Dr Suman Mallick, Kolkata

Dr Rajan Santosham, Chennai

Dr Vijay Anand Reddy,

Hyderabad

Dr S K Srivastav, Mumbai

Dr S V Srikrishna,

Bangalore

0620 - 0635 PM

Functional Lung Imaging for

Radiation planning for Lung

Cancer

Dr A K Anand, Delhi

0635 - 0650 PM

Consolidating primary in

metastastic NSCLC – who, when

and how

Dr Vineeta Goel, Delhi

0650 - 0715 PM

In Conversation – Interpreting CT

Scans after SBRT (when to do

biopsy)

Panelists -

Dr Ananda Selvakumar Pandy,

Madhurai

Dr Shikha Goyal, Chandigarh

Dr Abhishek Bansal, Delhi

Dr Anandmoyee Dhar, Delhi

Dr Abhishek Gupta, Delhi

Moderator -

Dr Naveen Mummudi,

Mumbai

0715 - 0730 PM Proton Therapy in Lung Cancer Dr Srinivas Chilukuri, Chennai Dr Sapna Nangia, Chennai

0730 - 0800 PM Aam aadmi with lung cancer - Find me a cost effective solution in Hall A

2020

NAL ONScientic Program

thSunday, 27 September 2020

HALL A

Time Topic Speaker/Panelist Moderator/Chairperson

0400 - 0430 PMCase based discussion on locally

advanced lung cancer

Panelists -

Dr T Raja, Chennai

Dr Tarun Batra, Varanasi

Dr Promila Pankaj, Delhi

Dr Kanika Sood, Delhi

Dr Manish Treepathy, Delhi

Moderator- Dr Charu

Garg, Delhi

0430 - 0445 PMPACIFIC Trial – Did it change the

practiceDr Sonam Puri, San Diego Dr P K Julka, Delhi

Dr Naresh Somani, Jaipur

Dr Hemant Malhotra, Jaipur0445 - 0500 PMParaneoplastic syndrome –

theoretical or is it practical Dr Abhishek Gulia, Delhi

Supported by Roche

0500 - 0530 PM

IMpower150: Atezolizumab plus

Bevacizumab plus chemotherapy –

First Line – Who Why When

Dr Ullas Batra, Delhi

Dr Vineet Talwar, Delhi

0530 - 0600 PM

Clinical Untility of Hybrid capture

based Liquid biopsy in Lung

Cancer

Dr Jeffery Ross, USA

0600 - 0615 PM

Adeno or Squam or

Adenosquam – Jumbled words or

biology: 1st line chemotherapy

for ADENO, SQUAM and

ADENOSQUAM

Dr T P Sahoo, BhopalDr Ashok K Vaid, Gurgaon

Dr Bharat Bhosle, Mumbai

0615 - 0645 PM

Supported by Astra Zeneca

Experience sharing on

Durvalumab for the Management

of stage III unresectable NSCLC

Dr Daniel Chan, Singapore

Expert Comments

Dr S H Advani, MumbaiOsimertinib adjuvant therapy in

patients (pts) with resected EGFR

mutated (EGFRm) NSCLC

(ADAURA)

Dr Bharat Vaswani, Hyderabad

2020

NAL ONScientic Program

rdSaturday, 3 October 2020

HALL A

Time Topic Speaker/Panelist Moderator/Chairperson

0645 - 0700 PM

ADENOCARCINOMA –

TARGETS- COST limitations –

what to do

Dr Sewanti Limaye, Mumbai

Dr Meenu Walia, Delhi

Dr Shyam Aggarwal, Delhi

Dr Ajay Bapna, Jaipur0700 - 0715 PM

ADENOCARCINOMA – TARGETS –

not EGFR ALK AND NOT ROS1:

CHEMOTHERAPY and targets how to

choose how to sequence

Dr Amit Aggarwal, Delhi

0715 - 0730 PMSmall cell LUNG cancer: Cost and

Immunotherapy – benefit, if yes to

whom, where does it really help

Dr Prabhat Malik, Delhi

0730 - 0800 PM Survivor Ship for Lung Cancer Mr Vivek Tomar, Patient Advocate

2020

NAL ONScientic Program

rdSaturday, 3 October 2020

2020

NAL ONScientic Program

rdSaturday, 3 October 2020HALL B

Time Topic Speaker/Panelist Moderator/Chairperson

0400 - 0430 PM Case based discussion on locally advanced lung cancer in Hall A

0430 - 0445 PMRadiation Induced Lung Injury in

world of IO Dr Anil Tibdewal, Mumbai Dr Munish Gairola, Delhi

Dr Sushma Agrawal,

Lucknow0445 - 0500 PM Adaptive RT in Lung Cancer Dr Tejinder Kataria, Gurugram

0500 - 0530 PM Pfizer Sponsored Session in Hall A

0530 - 0600 PM Roche Sponsored Session in Hall A

0600 - 0615 PM

Adeno or Squam or Adenosquam –

Jumbled words or biology: First line

IO for ADENO, SQUAM AND

ADENOSQUAM with or chemo that

is the question

Dr Anita Ramesh, Chennai

Dr Bijesh Raj Ghimire,

Nepal

Dr Adwaita Gore, Mumbai

0615 - 0645 PM Astra Zeneca Sponsored Session in Hall A

0645 - 0700 PM

ADENOCARCINOMA – NO

TARGETS Cost no limitations –

what to do

Dr Chirag Desai, Ahemdabad

Dr Kaustav Talpatre,

Mumbai0700 - 0715 PM

ADENOCARCINOMA – TARGETS

– not EGFR ALK AND NOT ROS1:

Immunotherapy how to choose

how to sequence

Dr Amit Rauthan, Bangalore

0715 - 0730 PM

Small cell LUNG cancer: Role of

consolidation in extensive stage –

who, when and how

Dr Pranav Chadha, Mumbai

0730 - 0800 PM Survivor Ship for Lung Cancer in Hall A

HALL A

Time Topic Speaker/Panelist Moderator/Chairperson

0400 - 0430 PMCase based discussion on pleural

effusion

Panelists -

Dr Ashish Kr Aggarwall, UP

Dr Pankaj Chhabra, Haryana

Dr Peeyush Bajpai, Delhi

Dr Priya Tiwari, Gurugram

Dr Sarvanna R, Coimbatore

Dr Sanjay Baijal, Gurugram

Moderator -

Dr Vivek Nangia, Delhi

Palliative Care

0430 - 0445 PMCough & Breathlessness– what to

do when all things failDr Nandini Vallath, Delhi

Dr Jayita Deodhar,

Mumbai

Dr Nevin Kishore, Delhi0445 - 0500 PM

When to counsel family about

end of life 10 days before or

100 days before

Dr Mary Ann Muckaden,

Mumbai

0500 - 0515 PMCord compression – Panel

Discussion

Panelists -

Dr Sushma Bhatnagar, Delhi

Dr Ritesh Sharma, Delhi

Dr Akshay Tiwari, Delhi

Dr V Srinivasan, Chennai

Moderator -

Dr Naveen Salins, Manipal

Supported by Astra Zeneca

0515 - 0545 PMOptimal management of EGFRm

metastatic NSCLC patientDr Suresh Ramalingam, USA

Moderator -

Dr Nitesh Rohatgi, Delhi

Chairperson -

Dr R Ranga Rao, Gurugram

Dr Shyam Aggarwal, Delhi

2020

NAL ONScientic Program

thSunday, 4 October 2020

2020

NAL ONScientic Program

thSunday, 4 October 2020HALL A

Time Topic Speaker/Panelist Moderator/Chairperson

Supported by Pfizer

0545 - 0615 PM ALK – Lorlatinib – Do we have

a One Size Fits All drugDr Sanjay Popat, UK

0615 - 0630 PM

Whats ur choice - Neoadjuvant

Chemo Theraphy vs Neoajuvant

CTRT for lung Cancer

Dr Manish Singhal, Delhi

Dr Anusheel Munshi, DelhiDr Vamshi Krishna,

Hyderabad

Dr Sandeep Goyle,

Mumbai0630 - 0645 PMManagement of RT necrosis in

era of TKIDr G S Bhattacharya, Kolkata

0645 - 0700 PMWhat are the must take away

from AYURVEDIC scienceDr Geeta Krishna, Gurugram Dr Nitesh Rohatgi, Delhi

0700 - 0730 PM ORAL POSTERS and 1 L prizeDr D Behra

Dr Arun Goel/ Dr Munish Gairola

Supported by Pfizer

0730 - 0800 PM EGFR TKI in the next 5 years Dr Tony Mok, Hong Kong

2020

NAL ONScientic Program

thSunday, 4 October 2020HALL B

Time Topic Speaker/Panelist Moderator/Chairperson

0400 - 0430 PM Case based discussion on pleural effusion in Hall A

Palliative Care

0430 - 0445 PMHaemoptysis in Lung Cancer –

Options/managementDr Rajiv Goyal, Delhi

Dr Manish Pandey, Delhi

Dr Sharad Joshi, Delhi0445 - 0500 PM

SVC obstruction – you don’t

suspect you wont find

Dr Amal Roy Choudhary,

Gurugram

0500 - 0515 PM Cord compression - Panel Discussion in Hall A

0515 - 0545 PM Astra Zeneca Sponsored Session in Hall A

0545 - 0615 PM Pfizer Sponsored Session in Hall A

0615 - 0630 PMRole of Adjuvant CT/TKIs – post

SBRT/lobectomyDr Senthil Rajappa, Hyderabad

Dr Palanki Satya

Dattatreya, Hyderabad

0630 - 0645 PMHow to judge a good from a

bad BIOSIMILAR

0645 - 0700 PM5 practice changing takes form

last 5 yearsDr B K Smruti, Mumbai

0700 - 0730 PM ORAL POSTERS and 1 L prize in Hall A

0730 - 0800 PM Pfizer Sponsored Session in Hall A

OFFICIAL VIRTUAL MEETING PARTNER